A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
about
Advances in deoxynivalenol toxicity mechanisms: the brain as a targetDeoxynivalenol Exposure Assessment for Pregnant Women in BangladeshAssessment of deoxynivalenol metabolite profiles in UK adultsA biomarker survey of urinary deoxynivalenol in China: the Shanghai Women's Health Study.Preliminary estimation of deoxynivalenol excretion through a 24 h pilot studyAssessment of Mycotoxin Exposure in Côte d'ivoire (Ivory Coast) Through Multi-Biomarker Analysis and Possible Correlation with Food Consumption PatternsTargets and intracellular signaling mechanisms for deoxynivalenol-induced ribosomal RNA cleavage.Identification of a novel human deoxynivalenol metabolite enhancing proliferation of intestinal and urinary bladder cells.The molecular epidemiology of chronic aflatoxin driven impaired child growth.Assessment of multi-mycotoxin exposure in southern Italy by urinary multi-biomarker determination.The role of biomarkers in evaluating human health concerns from fungal contaminants in food.Gender and geographical variability in the exposure pattern and metabolism of deoxynivalenol in humans: a review.Evidence of ochratoxin A conjugates in urine samples from infants and adults.Characterisation of aflatoxin and deoxynivalenol exposure among pregnant Egyptian women.Utilising an LC-MS/MS-based multi-biomarker approach to assess mycotoxin exposure in the Bangkok metropolitan area and surrounding provinces.Central inflammation and sickness-like behavior induced by the food contaminant deoxynivalenol: a PGE2-independent mechanism.Deoxynivalenol exposure assessment in young children in Tanzania.Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins.Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feedAssessment of Urinary Deoxynivalenol Biomarkers in UK Children and Adolescents.Fast and sensitive LC-MS/MS method measuring human mycotoxin exposure using biomarkers in urine.Annual variation of dietary deoxynivalenol exposure during years of different Fusarium prevalence: a pilot biomonitoring study.Humans significantly metabolize and excrete the mycotoxin deoxynivalenol and its modified form deoxynivalenol-3-glucoside within 24 hours.Risk assessment of deoxynivalenol in high-risk area of China by human biomonitoring using an improved high throughput UPLC-MS/MS method.Deoxynivalenol exposure assessment in a cohort of pregnant women from Bradford, UK.A comparative study of the human urinary mycotoxin excretion patterns in Bangladesh, Germany, and Haiti using a rapid and sensitive LC-MS/MS approachSynthesis of deoxynivalenol-3-ß-D-O-glucuronide for its use as biomarker for dietary deoxynivalenol exposureDirect quantification of deoxynivalenol glucuronide in human urine as biomarker of exposure to the Fusarium mycotoxin deoxynivalenolA pilot survey for Fusarium mycotoxin biomarkers in women from Golestan, northern IranBiomonitoring of Mycotoxins in Urine: Pilot Study in Mill Workers
P2860
Q27009156-751C7E0F-8332-4C2E-8105-11E002260773Q28608285-3FC553AC-142A-4DDF-BA4D-AE07CA253BA2Q34440893-68F89C35-6976-4C24-ADD9-F5E5996D9E58Q35209582-D2CADFBC-22E3-4DDD-9E40-532DDF55E5EDQ35232703-35AD6E7C-CD3F-466B-BA2E-B6578DB4634BQ35549557-F6E9A2BB-9C4D-445E-8D1F-11AFDF194C9CQ35969317-0581084C-AA78-41B0-86B8-C3BD452D5D3FQ37278192-14C1DDED-36A5-4718-AF7B-B4F5AE230711Q37437159-A7CE422E-0268-48A6-A422-0982EA135518Q37617791-CEC17A94-7D34-494E-AD70-00DCB8E7C70CQ38014991-526BA061-FD24-48D8-9AFD-AE28509BA6CEQ38908268-9FB2994F-3647-40D5-B823-A025A0CA7DF4Q39199837-EC2BACB1-637B-4088-A8C1-BB30A171049AQ39355569-5C6EC7F6-D9CB-41A7-8950-5BB1D1A1106AQ40225552-F8B26BAC-EEFD-4588-B449-74E170F416B8Q42727255-0CAFDBC8-3477-4DF2-8EC7-997EFA61194DQ43934940-442A7627-CE3E-4B0A-A067-A83C6F2791ACQ45206156-5E714CFB-267B-42FF-9E59-E4F0EAD61E1CQ47160469-9D65F0CE-90C3-46AE-B5C0-6B9352AB5CCFQ47550024-060B97CF-E48D-4AC9-8787-972CDC9ADD3DQ49047209-DC5BD320-1169-4AF0-9D82-5548B34364E8Q51251897-533DAAA1-6609-475C-B69B-8F63AE626F1FQ52626721-92B381BC-907B-4E55-8B72-5A31CDF70B05Q52678218-8C89479C-2747-4AA2-B4A5-2792DC77FD9CQ52845894-87BB4C86-BB77-4E67-89A2-42C54D677D39Q55110884-41F9D3C8-E766-4194-A1DB-4DC09E60EC0BQ56838911-4A52B241-C669-4069-8E3D-51145F0D0BB6Q56838918-4EC08527-9A50-4FF0-920C-09096C5674B6Q57157126-77BB643B-8C37-4ABC-BF4A-C3D6A4E29828Q57932579-0B336C07-1F75-4E13-A1CB-66BDD0BB5E67
P2860
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@en
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@en-gb
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@nl
type
label
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@en
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@en-gb
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@nl
prefLabel
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@en
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@en-gb
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@nl
P2093
P2860
P1433
P1476
A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.
@en
P2093
Anita Rajendram
Christopher P Wild
Julie Fisher
Kay L M White
Paul C Turner
Richard P Hopton
P2860
P304
P356
10.3109/1354750X.2010.495787
P577
2010-09-01T00:00:00Z